Name | cladribine |
---|---|
Synonyms |
Litak
CDA 2-Chloro-2'-deoxyadenosine 2-Chloro-9-(2-deoxy-β-D-arabinofuranosyl)adenine 2-Chloro-2'-deoxy-adenosine CldAdo EINECS 224-427-9 MFCD00153939 (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxyméthyl)tétrahydrofuran-3-ol 2-chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine Cladrivine 2CDA 2-Chloro-6-amino-9-(2-deoxy-b-D-erythro-pentofuranosyl)purine Cladaribine (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol 2-Chlorodeoxyadenosine leustatin (2R,3S,5R)-5-(6-Amino-2-chlor-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol 2-Chloro-2'-deoxy-b-adenosine 2-Chloro-2'-deoxy-β-adenosine 2-CL-DADO Cladribine Movectro Leustati adenosine, 2-chloro-2'-deoxy- |
Description | Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. Target: Adenosine DeaminaseCladribine possesses concentration-dependent apoptosis-inducing potential in the HSB2 cells. Cladribine inhibits growth of primary mast cell (MC) and the MC line HMC-1 in a dose-dependent manner, with lower IC50 values recorded in HMC-1.2 cells harboring KIT D816V compared to HMC-1.1 cells lacking KIT D816V. Cladribine (0.7-3.5 mM) and/or diltiazem (2.4 mM), is injected intraperitoneally into adult zebrafish and red blood cell (RBC) lysates are assayed by HPLC for levels of purine nucleotides (e.g. ATP), potential biomarkers of cardiovascular health. Diltiazem increased RBC ATP concentrations, which are inhibited by co-injection of cladribine. |
---|---|
Related Catalog | |
References |
Density | 2.0±0.1 g/cm3 |
---|---|
Boiling Point | 547.6±60.0 °C at 760 mmHg |
Melting Point | 181-185 °C(lit.) |
Molecular Formula | C10H12ClN5O3 |
Molecular Weight | 285.687 |
Flash Point | 285.0±32.9 °C |
Exact Mass | 285.062866 |
PSA | 119.31000 |
LogP | 0.02 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.871 |
Storage condition | 2-8°C |
Stability | Store in Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 + H311 + H331-H315-H319-H335 |
Precautionary Statements | Missing Phrase - N15.00950417-P261-P280-P302 + P352 + P312-P304 + P340 + P312-P403 + P233 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic |
Risk Phrases | R23/24/25;R36/37/38 |
Safety Phrases | S26-S37/39-S45-S36-S22 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | AU7357560 |
Precursor 3 | |
---|---|
DownStream 4 | |